Answers are grounded in this paper and cite their sources.
Parkinson’s disease (PD) is increasingly recognized as a disorder involving the gut-brain axis, yet genome-resolved characterization of bacterial and viral communities with metabolic context remains limited. Here, we performed deep shotgun metagenomic sequencing and fecal metabolomic profiling in a high-altitude cohort comprising patients with PD and environmentally matched spouse controls (living at approximately 1,900 m altitude). We reconstructed 455 species-level genome bins (SGBs) and 2,957 non-redundant viral operational taxonomic units (vOTUs), enabling high-resolution profiling of bacterial and viral community composition. Rather than a uniform shift of the entire microbial community, PD-associated variation involved specific bacterial, viral, and metabolic components. Indicator analysis identified 23 bacterial and 86 viral candidate indicators associated with PD or control status, with predicted temperate phages representing the predominant lifestyle category among indicator vOTUs. Several PD-associated bacterial indicators included taxa previously linked to anaerobic fermentation and short-chain fatty acid (SCFA)-associated metabolism, accompanied by increased fecal valerate. Abundance correlation analysis identified covariation patterns between bacterial and viral indicators, including associations between controls (CK)-associated Agathobacter faecis and Lachnospiraceae-linked vOTUs. Integrating microbial abundance profiles and metabolomic measurements revealed exploratory associations among microbial indicators and metabolic alterations associated with PD. Cross-layer analyses further showed reduced dispersion of microbial-metabolomic alignment patterns in PD samples, suggesting a more constrained ecological state. Together, these findings provide a genome-resolved view of bacterial, viral, and metabolic variation in the PD gut ecosystem, extending characterization of PD-associated dysbiosis beyond bacterial taxonomy and identifying candidate microbial indicators and metabolic alterations for further investigation. IMPORTANCE Parkinson’s disease (PD) is a complex neurological disorder in which interactions between the host and the gut ecosystem are increasingly recognized as relevant to disease-associated biological processes. Previous microbiome studies of Parkinson’s disease have largely focused on bacterial taxonomic changes, while gut viral communities and their relationships with microbial metabolism remain less characterized. In this study, we used genome-resolved metagenomics and metabolomics to characterize bacterial, viral, and metabolic components associated with PD in individuals with Parkinson’s disease and environmentally matched controls. Our findings provide a broader view of Parkinson’s disease-associated gut ecosystem alterations beyond bacterial composition alone, highlighting bacteriophages as an underexplored ecological component and identifying microbial indicators and metabolic alterations for future investigation.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: